Literature DB >> 2342058

Comparative reactivity of 1-carba-1-dethiacephalosporins with cephalosporins.

L C Blaszczak1, R F Brown, G K Cook, W J Hornback, R C Hoying, J M Indelicato, C L Jordan, A S Katner, M D Kinnick, J H McDonald.   

Abstract

Nine matched pairs of cephalosporins and their 1-carba-1-dethiacephalosporin analogues have been compared with regard to microbiological activity, beta-lactam carbonyl infrared absorption, and aqueous stability. In general the microbiological activity of the pairs of compounds were very similar across a broad range of bacteria. The infrared absorption bands for the beta-lactam carbonyls of the pairs indicated a general trend for the 1-carba-1-dethiacephalosporins to absorb at lower frequencies than the corresponding cephalosporins. All of the 1-carba-1-dethiacephalosporins did however present a striking stability enhancement over their cephalosporin counterparts at pH = 10 or 11 in water. This marked contrast of MIC similarity with the observed differences in chemical reactivity clearly demonstrates hydroxide ion catalyzed hydrolysis is not a good model for transpeptidase activity unless the compounds comprise a limited domain of structural type.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2342058     DOI: 10.1021/jm00168a019

Source DB:  PubMed          Journal:  J Med Chem        ISSN: 0022-2623            Impact factor:   7.446


  4 in total

1.  N-thiolated beta-lactams: Studies on the mode of action and identification of a primary cellular target in Staphylococcus aureus.

Authors:  Kevin D Revell; Bart Heldreth; Timothy E Long; Seyoung Jang; Edward Turos
Journal:  Bioorg Med Chem       Date:  2006-12-20       Impact factor: 3.641

2.  Pharmaceutical properties of loracarbef: the remarkable solution stability of an oral 1-carba-1-dethiacephalosporin antibiotic.

Authors:  C E Pasini; J M Indelicato
Journal:  Pharm Res       Date:  1992-02       Impact factor: 4.200

3.  Loracarbef versus penicillin V in the treatment of streptococcal pharyngitis and tonsillitis.

Authors:  O Müller; Z Spirer; K Wettich
Journal:  Infection       Date:  1992 Sep-Oct       Impact factor: 3.553

4.  Comparison of loracarbef (LY163892) versus amoxicillin in the treatment of bronchopneumonia and lobar pneumonia.

Authors:  O Müller; K Wettich
Journal:  Infection       Date:  1992 May-Jun       Impact factor: 3.553

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.